SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($) |
12 Months Ended | |
---|---|---|
Dec. 31, 2022 |
Dec. 31, 2021 |
|
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | ||
Expenses for options and warrants granted to employees | $ 2,700,000 | $ 3,000,000.0 |
Epenses for R & D obligation | 500,000 | 300,000 |
Expenses was attributed to SG&A | $ 2,200,000 | $ 2,700,000 |
Common Shares From Convertible Debentures And Related Accrued Interest | 53,546 | 53,076 |
Current Federal Deposit Insurance | $ 250,000 | |
External Expenses | 1,400,000 | $ 1,600,000 |
Internal Expenses | 1,500,000 | 800,000,000,000 |
Amortization Of The R & D Obligation | 774,025 | 555,745 |
Amortization attributable to related parties | $ 193,610 | $ 150,805 |
Common Shares Issuable Upon The Exercise Of Outstanding Stock Options And Warrants | 6,267,602 | 7,250,206 |
Current FDIC limit | $ 250,000 |
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Amount of expense for Federal Deposit Insurance Corporation (FDIC) insurance. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of other research and development expense. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The amount of purchased research and development assets that are acquired in a business combination have no alternative future use and are therefore written off in the period of acquisition. No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|